Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term positron-emission-tomography. Found 29 abstracts

no pagination
Abel GA, Vanderplas A, Rodriguez MA, Crosby AL, Czuczman MS, Niland JC, Gordon LI, Millenson M, Zelenetz AD, Friedberg JW, LaCasce AS. High rates of surveillance imaging for treated diffuse large B-cell lymphoma: findings from a large national database. Leukemia & lymphoma. 2012 Jun;53(6):1113-6.   PMCID: not NIH funded
Chen JQ, Russo J. Dysregulation of glucose transport, glycolysis, TCA cycle and glutaminolysis by oncogenes and tumor suppressors in cancer cells. Biochimica Et Biophysica Acta-Reviews on Cancer. 2012 Dec;1826(2):370-84.   PMCID: not NIH funded
Colt DG, Andtbacka R, Anker CJ, Bichakjian CK, Carson WE, Daud A, Dilawari RA, DiMaio D, Guild V, Halpern AC, Hodi FS, Kelley MC, Khushalani NI, Kudchadkar RR, Lange JR, Lind A, Martini MC, Olszanski AJ, Pruitt SK, Ross MI, Swetter SM, Tanabe KK, Thompson JA, Trisal V, Urist MM. Melanoma. Journal of the National Comprehensive Cancer Network. 2012 Mar;10(3):366-400.   PMCID: not NIH funded
Ettinger DS, Akerley W, Borghaei H, Chang A, Cheney RT, Chirieac LR, D'Amico TA, Demmy TL, Ganti AK, Govindan R, Grannis FW, Horn L, Jahan TM, Jahanzeb M, Kessinger A, Komaki R, Kong FM, Kris MG, Krug LM, Lennes IT, Loo BW, Martins R, O'Malley J, Osarogiagbon RU, Otterson GA, Patel JD, Pinder-Schenck M, Pisters KM, Reckamp K, Riely GJ, Rohren E, Swanson SJ, Wood DE, Yang SC. Malignant Pleural Mesothelioma. Journal of the National Comprehensive Cancer Network. 2012 Jan;10(1):26-41.   PMCID: not NIH funded
Hoppe RT, Advani RH, Ai WY, Ambinder RF, Aoun P, Bello CM, Bierman PJ, Blum KA, Chen R, Dabaja B, Duron Y, Forero A, Gordon LI, Hernandez-Ilizaliturri FJ, Hochberg EP, Maloney DG, Mansur D, Mauch PM, Metzger M, Moore JO, Morgan D, Moskowitz CH, Poppe M, Pro B, Winter JN, Yahalom J, Sundar H. Hodgkin Lymphoma, Version 2.2012 Featured Updates to the NCCN Guidelines. Journal of the National Comprehensive Cancer Network. 2012 May;10(5):589-97.   PMCID: not NIH funded
Kim HJ, Barsevick AM, Fang CY, Miaskowski C. Common Biological Pathways Underlying the Psychoneurological Symptom Cluster in Cancer Patients. Cancer nursing. 2012 Nov;35(6):E1-E20.   PMCID: not NIH funded
Konski A, Li TY, Christensen M, Cheng JD, Yu JQ, Crawford K, Haluszka O, Tokar J, Scott W, Meropol NJ, Cohen SJ, Maurer A, Freedman GM. Symptomatic cardiac toxicity is predicted by dosimetric and patient factors rather than changes in F-18-FDG PET determination of myocardial activity after chemoradiotherapy for esophageal cancer. Radiotherapy and Oncology. 2012 Jul;104(1):72-7.   PMCID: PMC3389132
Miller J, Doss M, McQuillen R, Shaller CC, Tolner B, Yu JQ, Chester K, Robinson MK. Impact of expression system on the function of the C6.5 diabody PET radiotracer. Tumor Biology. 2012 Jun;33(3):617-27.   PMCID: not NIH funded
Motzer RJ, Agarwal N, Beard C, Bhayani S, Bolger GB, Buyyounouski MK, Carducci MA, Chang SS, Choueiri TK, Gupta S, Hancock SL, Hudes GR, Jonasch E, Kuzel TM, Lau C, Levine EG, Lin DW, Margolin KA, Michaelson MD, Olencki T, Pili R, Ratliff TW, Redman BG, Robertson CN, Ryan CJ, Sheinfeld J, Wang J, Wilder RB. Testicular Cancer Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network. 2012 Apr;10(4):502-35.   PMCID: not NIH funded
Shanmugan S, Arrangoiz R, Nitzkorski JR, Yu JQ, Li TY, Cooper H, Konski A, Farma JM, Sigurdson ER. Predicting Pathological Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer Using (18)FDG-PET/CT. Annals of Surgical Oncology. 2012 Jul;19(7):2178-85.
Tejani MA, Burtness BA. Multi-Modality Therapy for Cancer of the Esophagus and GE Junction. Current treatment options in oncology. 2012 Sep;13(3):390-402.   PMCID: Not NIH funded
Van den Abbeele AI, Gatsonis C, De Vries DJ, Melenevsky Y, Szot-Barnes A, Yap JT, Godwin AK, Rink L, Huang M, Blevins M, Sicks J, Eisenberg B, Siegel BA. ACRIN 6665/RTOG 0132 Phase II Trial of Neoadjuvant Imatinib Mesylate for Operable Malignant Gastrointestinal Stromal Tumor: Monitoring with F-18-FDG PET and Correlation with Genotype and GLUT4 Expression. Journal of Nuclear Medicine. 2012 Apr;53(4):567-74.
Wai CJ. Other Methods of Axillary Assessment and Their Value. Current Problems in Cancer. 2012 Sep;36(5):292-304.   PMCID: Not NIH Funded
Ajani JA, Barthel JS, Bentrem DJ, D'Amico TA, Das P, Denlinger CS, Fuchs CS, Gerdes H, Glasgow RE, Hayman JA, Hofstetter WL, Ilson DH, Keswani RN, Kleinberg LR, Korn M, Lockhart AC, Mulcahy MF, Orringer MB, Osarogiagbon RU, Posey JA, Sasson AR, Scott WJ, Shibata S, Strong VE, Varghese TK, Warren G, Washington MK, Willett C, Wright CD, Meron Aj VP. Esophageal and Esophagogastric Junction Cancers. Journal of the National Comprehensive Cancer Network. 2011 Aug;9(8):830-+.   PMCID: not NIH funded
Anderson KC, Alsina M, Bensinger W, Biermann JS, Chanan-Khan A, Cohen AD, Devine S, Djulbegovic B, Faber EA, Gasparetto C, Huff CA, Kassim A, Medeiros BC, Meredith R, Raje N, Schriber J, Singhal S, Somlo G, Stockerl-Goldstein K, Treon SP, Tricot G, Weber DM, Yahalom J, Yunus F. Multiple Myeloma. Journal of the National Comprehensive Cancer Network. 2011 Oct;9(10):1146-83.   PMCID: not NIH funded
Dawood S, Merajver SD, Viens P, Vermeulen PB, Swain SM, Buchholz TA, Dirix LY, Levine PH, Lucci A, Krishnamurthy S, Robertson FM, Woodward WA, Yang WT, Ueno NT, Cristofanilli M. International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment. Annals of Oncology. 2011 Mar;22(3):515-23.   PMCID: PMC3105293
Ettinger DS, Agulnik M, Cates JM, Cristea M, Denlinger CS, Eaton KD, Fidias PM, Gierada D, Gockerman JP, Handorf CR, Iyer R, Lenzi R, Phay J, Rashid A, Saltz L, Shulman LN, Smerage JB, Varadhachary GR, Zager JS, Zhen WN. Occult Primary Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network. 2011 Dec;9(12):1358-95.   PMCID: not NIH funded
Hoppe RT, Advani RH, Ai WY, Ambinder RF, Bello CM, Bierman PJ, Blum KA, Dabaja B, Duron Y, Forero A, Gordon LI, Hernandez-Ilizaliturri FJ, Hochberg EP, Maloney DG, Mansur D, Mauch PM, Metzger M, Moore JO, Morgan D, Moskowitz CH, Poppe M, Pro B, Weiss L, Winter JN, Yahalom J, Nccn Clinical Practice Guidelines, Rbone Pp VP, Nellos Gp VP, Nellos Gp VP. NCCN Clinical Practice Guidelines in Oncology for Hodgkin Lymphoma. Journal of the National Comprehensive Cancer Network. 2011 Sep;9(9):1020-58.   PMCID: not NIH funded
Kalemkerian GP, Akerley W, Bogner P, Borghaei H, Chow L, Downey RJ, Gandhi L, Ganti AK, Govindan R, Grecula JC, Hayman J, Heist RS, Horn L, Jahan TM, Koczywas M, Moran CA, Niell HB, O'Malley J, Patel JD, Ready N, Rudin CM, Williams CC. Small Cell Lung Cancer. Journal of the National Comprehensive Cancer Network. 2011 Oct;9(10):1086-113.   PMCID: not NIH funded
Swaby RF, Cristofanilli M. Circulating tumor cells in breast cancer: A tool whose time has come of age. BMC Medicine. 2011 Apr;9:43.   PMCID: PMC3107794
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term positron-emission-tomography

positron-emission-tomography NCCN Guidelines chemotherapy NCCN Clinical Practice Guidelines carcinoma fdg-pet squamous-cell carcinoma stem-cell transplantation radiotherapy management phase-ii trial breast-cancer cooperative-oncology-group intensity-modulated radiotherapy radiation therapy high-dose therapy term-follow-up esophagogastric cancer follow-up survival surgery resection therapy combined-modality metastatic early prediction junction randomized controlled-trial fine-needle-aspiration randomized dose hemithoracic radiation biopsy germ-cell tumors corticotropin-releasing hormone surgical excision indiana-university experience factor-i 1993 rousos ga-jama-journal of the american medical association-v269-p2110 donor lymphocyte infusions occult primary guidelines mutations FDG-PET surgical gemcitabine bone-marrow transplantation progression 1995 ow wh-v274-p474 phase-iii controlled-trial multicenter phase-ii colony-stimulating factor chain-reaction assay poorly enzyme fusion pet combination phase-ii cytogenetics 2007 doloff da-v5-ps1 daily thoracic radiotherapy human lactate dehydrogenase stage-iii unknown primary site lymph node dissection eortc-soft-tissue rates Hodgkin disease sided complete definitive chemoradiotherapy randomized-trial receiving adjuvant chemotherapy thalidomide plus neoadjuvant chemotherapy high-grade dysplasia 1984 orman ra-nature-v309-p467 remission bisphosphonates high response cisplatin plus proteasome inhibitor neuroendocrine tumors preoperative chemoradiation primary amyloidosis forthcoming 7th edition sleep-wake cycle small recombinant interleukin-2 therapy 2010 ung pw-j clin oncol-v28 phase-iii trial salvage chemotherapy treatment rhoc-gtpase concurrent chemoradiotherapy minimally invasive esophagectomy multicenter randomized-trial pemetrexed plus cisplatin pichia-pastoris carcinoma of unknown primary bone-sarcoma-group chemoradiation therapy 2011 ung p-j natl cancer i-v103-p194 1993 n jkl-journal of dermatologic surgery and oncology-v19-p985 pegylated liposomal doxorubicin dexamethasone seminoma metastases diagnostic imaging Diff use large B-cell lymphoma-health services research lymphocyte predominance c-Myc p53-Glucose transporter-Glycolysis-TCA cycle-Glutaminolysis skin 2009 carthy pl-blood-v114 trimodality therapy free survival blood high-dose stem cell transplant cancer-research-network 2002 ung p-can j urol-v9-p1637 gastroesophageal junction 2007 doloff da-v5-ps23 multidisciplinary care radiation-therapy monoclonal-antibody lymphoma HER2 Diabody-Pichia-E coli-PET imaging major-depressive-disorder pathology involved-field defects Multimodality therapy Esophageal carcinoma-Neoadjuvant therapy-Chemotherapy-Radiotherapy-Gastroesophageal junction (GEJ)-Esophageal cancer-Treatment system cell quality-of-life pleural effusion isolated limb perfusion biologic therapy pathological response C-reactive protein study-group ghsg esophageal stage-iii melanoma lymph-node dissection inflammatory breast cancer preoperative chemoradiation therapy 2 cycles combination-chemotherapy regimens
Last updated on Friday, July 10, 2020